Michael Sen

Since 2022, Michael Sen has been CEO of Fresenius SE & Co. KGaA, a global healthcare group that provides products and services for leading therapies with annual revenues of more than 40 billion Euros and over 300,000 employees worldwide, and is one of the most important managers in the global healthcare industry.

Mr. Sen was appointed to the management board of Fresenius in 2021 and CEO of Fresenius Kabi AG, a healthcare company and subsidiary of Fresenius with more than 40,000 employees. Prior to that, he was a member of the management board of Siemens AG after serving as Chief Financial Officer (CFO) of E.ON SE. Mr. Sen began his career at Siemens and held various positions, inculding member of the management board and CFO of the company’s Health Care division.

Mr. Sen obtained his vocational training at Siemens and subsequently studied business administration at the Technical University of Berlin.